Skip to content

Minerva Neurosciences, Inc.

NERV· NasdaqCore metricsCIK 1598646

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -6.27%
Market cap
$119.11M
49.84M shares
Filings
650
$0.00
FY 2024
$100.75M
Q3 2026N/M FY25 yoy
-$9.43M
Q3 2026N/M FY25 yoy
-$24.66M
FY 2022derivedN/M FY22 yoy
-$0.19
Q3 2026N/M FY25 yoy
$20.22M
Q3 2026+285.3% FY25 yoy
$119.11M
—
—
—
—
—

FY2025 figures · derived

Price

$2.3939.80%$1.58past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2024
$0.000FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024
PeriodEndedValueKindSource trail
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported
FY 20222022-12-31$0reported
FY 20212021-12-31$0reported
FY 20202020-12-31$0 revisedreported
FY 20192019-12-31$0reported
FY 20182018-12-31$0reported
FY 20172017-12-31$0reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2017—$389.00$389.00—38.75M sh+9.8%0.0%

Pharmaceutical preparations

Minerva Neurosciences, Inc. is the 282nd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Minerva Neurosciences, Inc. · CIK 1598646 · Engraved from SEC EDGAR